LivaNova PLC (NASDAQ: LIVN) stock closed at 54.79 per share at the end of the most recent trading day (a -5.76% change compared to the prior day closing price) with a volume of 492.93K shares and market capitalization of 2.93B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 4000 people. LivaNova PLC CEO is Damien McDonald.

The one-year performance of LivaNova PLC stock is -20.73%, while year-to-date (YTD) performance is -1.35%. LIVN stock has a five-year performance of -34.23%. Its 52-week range is between 41.82 and 88, which gives LIVN stock a 52-week price range ratio of 28.09%

LivaNova PLC currently has a PE ratio of -33.10, a price-to-book (PB) ratio of 2.63, a price-to-sale (PS) ratio of 4.01, a price to cashflow ratio of 35.50, a PEG ratio of 2.32, a ROA of -4.56%, a ROC of -4.13% and a ROE of -8.24%. The company’s profit margin is -11.77%, its EBITDA margin is 1.70%, and its revenue ttm is $746.93 Million , which makes it $13.96 revenue per share.

Of the last four earnings reports from LivaNova PLC, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.72 for the next earnings report. LivaNova PLC’s next earnings report date is 22nd Feb 2023.

The consensus rating of Wall Street analysts for LivaNova PLC is Strong Buy (1.5), with a target price of $80.57, which is +47.05% compared to the current price. The earnings rating for LivaNova PLC stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

LivaNova PLC has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

LivaNova PLC has a Buy technical analysis rating based on Technical Indicators (ADX : 21.32, ATR14 : 1.68, CCI20 : 186.94, Chaikin Money Flow : 0.09, MACD : 0.50, Money Flow Index : 59.05, ROC : 2.87, RSI : 62.52, STOCH (14,3) : 76.34, STOCH RSI : 1.00, UO : 50.82, Williams %R : -23.66), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of LivaNova PLC in the last 12-months were: Alex Shvartsburg (Option Excercise at a value of $-32 682), Alfred J Novak (Option Excercise at a value of $0), Andrea L. Saia (Option Excercise at a value of $0), Arthur L Rosenthal (Option Excercise at a value of $0), Damien McDonald (Option Excercise at a value of $0), Damien McDonald (Sold 5 004 shares of value $348 019 ), Daniel Jeffrey Moore (Option Excercise at a value of $0), Daniel Jeffrey Moore (Sold 3 000 shares of value $243 416 ), Francesco Bianchi (Option Excercise at a value of $0), Keyna Pidcock Skeffington (Option Excercise at a value of $0), Marco Dolci (Option Excercise at a value of $0), Sharon O'Kane (Option Excercise at a value of $0), Stacy Enxing Seng (Option Excercise at a value of $0), Todd C. Schermerhorn (Option Excercise at a value of $0), Trui Hebbelinck (Option Excercise at a value of $0), William A. Kozy (Option Excercise at a value of $0)